Published in J Clin Microbiol on April 01, 2002
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis (2006) 1.39
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23
Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. Transplantation (2007) 1.07
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol (2007) 1.04
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol (2005) 1.02
Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. J Clin Microbiol (2004) 1.01
Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J Clin Microbiol (2008) 0.93
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax (2004) 0.90
Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom. J Clin Microbiol (2003) 0.85
Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain. Eur J Clin Microbiol Infect Dis (2012) 0.83
Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology. Eur J Clin Microbiol Infect Dis (2016) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Burkholderia cepacia. Management issues and new insights. Clin Chest Med (1998) 3.23
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med (2001) 2.55
Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr (2001) 2.31
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Inhibition of DNAse activity in PFGE analysis of DNA from Campylobacter jejuni. Lett Appl Microbiol (1994) 2.22
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol (1996) 1.60
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis (2001) 1.11
Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest (1993) 0.94
Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres. J Hosp Infect (1998) 0.88
Genetic relatedness of Burkholderia (Pseudomonas) cepacia isolates from five cystic fibrosis centers in Michigan. Respir Med (1997) 0.85
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol (2002) 3.44
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility. Proc Natl Acad Sci U S A (2006) 3.07
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol (2009) 2.61
Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol (2003) 2.49
Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury. Circ Res (2006) 2.49
PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol (2004) 2.31
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc (2013) 2.05
Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis (2002) 1.88
Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol (2002) 1.87
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet (2013) 1.86
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol (2002) 1.86
Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol (2002) 1.79
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl Environ Microbiol (2005) 1.62
Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting. Diabetes Care (2011) 1.60
Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int J Syst Evol Microbiol (2004) 1.58
Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1. Am J Physiol Cell Physiol (2011) 1.55
Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One (2012) 1.40
Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40
H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J (2006) 1.40
Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant. Genome Res (2011) 1.38
Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett (2003) 1.38
Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med (2008) 1.37
Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis (2007) 1.36
Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. J Clin Microbiol (2003) 1.35
Use of the gyrB gene for the identification of Pandoraea species. FEMS Microbiol Lett (2002) 1.33
Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Dis (2002) 1.31
Comparison of matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis. J Clin Microbiol (2013) 1.30
Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J Infect Dis (2010) 1.29
Recognition of heptoses and the inner core of bacterial lipopolysaccharides by surfactant protein d. Biochemistry (2007) 1.28
Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr (2003) 1.28
Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov. Int J Syst Evol Microbiol (2003) 1.28
Promoting an environment of professionalism: the University of Chicago "Roadmap". Acad Med (2007) 1.27
Expanded multilocus sequence typing for burkholderia species. J Clin Microbiol (2009) 1.26
Using BOX-PCR to exclude a clonal outbreak of melioidosis. BMC Infect Dis (2007) 1.24
Multilocus sequence typing breathes life into a microbial metagenome. PLoS One (2006) 1.23
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23
Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol (2013) 1.21
Divergence and mosaicism among virulent soil phages of the Burkholderia cepacia complex. J Bacteriol (2006) 1.20
Ligand specificity of human surfactant protein D: expression of a mutant trimeric collectin that shows enhanced interactions with influenza A virus. J Biol Chem (2005) 1.17
Use of social media by residency program directors for resident selection. Am J Health Syst Pharm (2010) 1.16
Molecular epidemiology of Burkholderia species. Front Biosci (2003) 1.16
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infect Control Hosp Epidemiol (2007) 1.16
Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients. Int J Syst Evol Microbiol (2003) 1.15
Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe (2009) 1.15
Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol (2014) 1.13
European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros (2011) 1.12
Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology (2003) 1.12
Mapping loci associated with tail color and sex determination in the short-lived fish Nothobranchius furzeri. Genetics (2009) 1.12
Culture-based and non-growth-dependent detection of the Burkholderia cepacia complex in soil environments. Appl Environ Microbiol (2002) 1.11
Functional analysis of maize RAD51 in meiosis and double-strand break repair. Genetics (2007) 1.09
Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clin Infect Dis (2003) 1.08
Species differences in the carbohydrate binding preferences of surfactant protein D. Am J Respir Cell Mol Biol (2006) 1.08
Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively. Syst Appl Microbiol (2013) 1.05
C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Res (2005) 1.05
Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J (2009) 1.05
Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell Microbiol (2006) 1.05
Recovery of human papillomavirus nucleic acids from liquid-based cytology media. J Virol Methods (2006) 1.05
Experimental infection of dusky-footed wood rats (Neotoma fuscipes) with Ehrlichia phagocytophila sensu lato. J Wildl Dis (2002) 1.04
Observing and improving hand hygiene compliance: implementation and refinement of an electronic-assisted direct-observer hand hygiene audit program. Infect Control Hosp Epidemiol (2012) 1.04
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol (2007) 1.04
Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant (2002) 1.04
Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens. J Clin Microbiol (2011) 1.03
Involvement of a quorum-sensing-regulated lipase secreted by a clinical isolate of Burkholderia glumae in severe disease symptoms in rice. Appl Environ Microbiol (2007) 1.02
Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343. Biochemistry (2009) 1.02
Vitamin d deficiency in cystic fibrosis. Int J Endocrinol (2010) 1.02
Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros (2006) 1.01
Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site. J Mol Biol (2002) 1.01
Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis). J Clin Microbiol (2003) 1.01
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc (2014) 1.00
Mapping of quantitative trait loci controlling lifespan in the short-lived fish Nothobranchius furzeri--a new vertebrate model for age research. Aging Cell (2012) 1.00
Genes in congenital heart disease: atrioventricular valve formation. Basic Res Cardiol (2008) 0.98
Lactobacillus gasseri causing Fournier's gangrene. Scand J Infect Dis (2004) 0.98
Structural and functional insights into the regulation of Arabidopsis AGC VIIIa kinases. J Biol Chem (2006) 0.98
Burkholderia cenocepacia ET12 strain activates TNFR1 signalling in cystic fibrosis airway epithelial cells. Cell Microbiol (2007) 0.97
A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun (2008) 0.97
Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest (2007) 0.97
Management of osteoporosis in adults with cystic fibrosis. Drugs (2004) 0.96
Contributions of phenylalanine 335 to ligand recognition by human surfactant protein D: ring interactions with SP-D ligands. J Biol Chem (2006) 0.96
Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol (2004) 0.96
Microbial diversity in the cystic fibrosis airways: where is thy sting? Future Microbiol (2012) 0.96
SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab Invest (2012) 0.95
Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J Clin Microbiol (2012) 0.95
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant (2013) 0.95
Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med (2012) 0.94
Critical role of Arg/Lys343 in the species-dependent recognition of phosphatidylinositol by pulmonary surfactant protein D. Biochemistry (2007) 0.94
Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors. PLoS Genet (2012) 0.94
Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus. Biochem J (2008) 0.94
Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol (2003) 0.93
Burkholderia glumae infection in an infant with chronic granulomatous disease. J Clin Microbiol (2006) 0.93
Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax (2011) 0.92
Bmp signaling exerts opposite effects on cardiac differentiation. Circ Res (2012) 0.92
Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis. FEMS Immunol Med Microbiol (2004) 0.92